[CRVS] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
08-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 26.07%
YoY- 21.30%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 0 246 0 0 0 0 0 -
PBT -5,701 -6,653 -6,000 -6,503 -7,873 -9,816 -14,831 -47.10%
Tax -20 -95 -425 -403 923 6,384 -225 -80.05%
NP -5,701 -6,653 -6,000 -6,503 -8,796 -16,200 -14,831 -47.10%
Tax Rate - - - - - - - -
Total Cost 5,701 6,899 6,000 6,503 8,796 16,200 14,831 -47.10%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 0.00 -2,704.47 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.12 -0.14 -0.12 -0.14 -0.19 -0.35 -0.32 -47.96%
EPS Diluted -0.12 -0.14 -0.12 -0.14 -0.19 -0.35 -0.32 -47.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.